Published in Eur J Clin Invest on January 01, 2010
A compendium of genome-wide associations for cancer: critical synopsis and reappraisal. J Natl Cancer Inst (2010) 2.00
Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants. Public Health Genomics (2011) 1.96
Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer. Trends Genet (2010) 1.83
A population approach to precision medicine. Am J Prev Med (2012) 1.44
Consistency of genome-wide associations across major ancestral groups. Hum Genet (2011) 1.35
Users' motivations to purchase direct-to-consumer genome-wide testing: an exploratory study of personal stories. J Community Genet (2011) 1.28
Being more realistic about the public health impact of genomic medicine. PLoS Med (2010) 1.06
Genome-wide association studies and genetic risk assessment of liver diseases. Nat Rev Gastroenterol Hepatol (2010) 0.99
Personal genetics: regulatory framework in Europe from a service provider's perspective. Eur J Hum Genet (2010) 0.98
Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Epidemiol (2011) 0.94
A systems genetics approach provides a bridge from discovered genetic variants to biological pathways in rheumatoid arthritis. PLoS One (2011) 0.87
The genetics of breast cancer: risk factors for disease. Appl Clin Genet (2011) 0.81
Limitations of medical research and evidence at the patient-clinician encounter scale. Chest (2013) 0.79
Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Hum Genet (2011) 0.79
Role of genomics in cardiovascular medicine. World J Cardiol (2010) 0.77
De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry (2011) 4.91
Familial aggregation of Parkinson's disease in Iceland. N Engl J Med (2000) 2.41
The mutation rate in the human mtDNA control region. Am J Hum Genet (2000) 2.40
Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39
S-100 protein in soft-tissue tumors derived from Schwann cells and melanocytes. Am J Pathol (1982) 2.31
Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry (2009) 2.29
Ethics of population genomics research. Nature (1999) 2.20
Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol Med (1995) 2.15
The genetic spectrum of a population-based sample of familial hemiplegic migraine. Brain (2006) 1.97
Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am J Hum Genet (2005) 1.91
Allelic frequencies and patterns of single-nucleotide polymorphisms in candidate genes for asthma and atopy in Iceland. Am J Respir Crit Care Med (2001) 1.89
Contribution of ADAM33 polymorphisms to the population risk of asthma. Thorax (2005) 1.76
Determination of contiguity of subclones using the polymerase chain reaction. Nucleic Acids Res (1988) 1.62
Population genomics: laying the groundwork for genetic disease modeling and targeting. Clin Chem Lab Med (1998) 1.59
Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study. Ann Rheum Dis (2010) 1.53
Genetic factors contribute to the risk of developing endometriosis. Hum Reprod (2002) 1.42
An alternatively spliced region of the human hexabrachion contains a repeat of potential N-glycosylation sites. Proc Natl Acad Sci U S A (1989) 1.41
Expanding the range of ZNF804A variants conferring risk of psychosis. Mol Psychiatry (2010) 1.41
Distribution of S-100 protein outside the central nervous system. Brain Res (1982) 1.37
S-100 protein in human chondrocytes. Nature (1982) 1.35
Identification of a novel neuregulin 1 at-risk haplotype in Han schizophrenia Chinese patients, but no association with the Icelandic/Scottish risk haplotype. Mol Psychiatry (2004) 1.32
Sharing of antigenic determinants between the nicotinic acetylcholine receptor and proteins in Escherichia coli, Proteus vulgaris, and Klebsiella pneumoniae. Possible role in the pathogenesis of myasthenia gravis. N Engl J Med (1985) 1.26
The oligodendrocyte-myelin glycoprotein belongs to a distinct family of proteins and contains the HNK-1 carbohydrate. J Cell Biol (1990) 1.19
Circulating autoantibodies to the 200,000-dalton protein of neurofilaments in the serum of healthy individuals. Science (1985) 1.16
Immunohistochemistry of retinoblastomas in humans. Am J Ophthalmol (1984) 1.14
Identification of Gal(beta 1-3)GalNAc bearing glycoproteins at the nodes of Ranvier in peripheral nerve. J Neurosci Res (1994) 1.11
Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM. Mol Psychiatry (2011) 1.08
The genealogic approach to human genetics of disease. Cancer J (2001) 1.06
S-100 protein in granular cell tumors (granular cell myoblastomas). Cancer (1982) 1.05
Proligodendroblast antigen (POA), a developmental antigen expressed by A007/O4-positive oligodendrocyte progenitors prior to the appearance of sulfatide and galactocerebroside. J Neurochem (1992) 1.03
A role for the acetylcholine receptor-inducing protein ARIA in oligodendrocyte development. Proc Natl Acad Sci U S A (1994) 1.03
A common biological basis of obesity and nicotine addiction. Transl Psychiatry (2013) 1.01
Association between IL-1beta/TNF-alpha-induced glucocorticoid-sensitive changes in multiple gene expression and altered responsiveness in airway smooth muscle. Am J Respir Cell Mol Biol (2001) 1.01
A phosphatidylinositol-linked peanut agglutinin-binding glycoprotein in central nervous system myelin and on oligodendrocytes. J Cell Biol (1988) 1.00
Expression of the oligodendrocyte-myelin glycoprotein by neurons in the mouse central nervous system. J Neurochem (1998) 1.00
Neuropathy accompanying IgM lambda monoclonal gammopathy. Acta Neuropathol (1983) 1.00
Psoriasis patients who are homozygous for the HLA-Cw*0602 allele have a 2.5-fold increased risk of developing psoriasis compared with Cw6 heterozygotes. Br J Dermatol (2003) 0.99
Distribution of the neuronal specific protein, 14-3-2, in central nervous system lesions of tuberous sclerosis. Acta Neuropathol (1981) 0.98
Gangliosides of human spinal cord: aberrant composition of cords from patients with amyotrophic lateral sclerosis. J Neurosci Res (1984) 0.97
Distribution of glial fibrillary acidic protein in central nervous system lesions of tuberous sclerosis. Acta Neuropathol (1980) 0.95
The complete cDNA sequence of human hexabrachion (Tenascin). A multidomain protein containing unique epidermal growth factor repeats. J Biol Chem (1991) 0.94
Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clin Exp Immunol (1990) 0.94
Two large glycosylated polypeptides found in myelinating oligodendrocytes but not in myelin. Proc Natl Acad Sci U S A (1986) 0.92
Structure of the human hexabrachion (tenascin) gene. Proc Natl Acad Sci U S A (1991) 0.92
Inhibition of T cell activation by the extracellular matrix protein tenascin. J Immunol (1994) 0.91
Maintenance of isolated oligodendrocytes in long-term culture. Brain Res (1980) 0.89
An Icelandic saga on a centralized healthcare database and democratic decision making. Nat Biotechnol (1999) 0.89
The role of linkage studies for common diseases. Curr Opin Genet Dev (2001) 0.88
Structure and chromosomal localization of the human gene for a brain form of prostaglandin D2 synthase. J Biol Chem (1992) 0.88
Rejection of fetal neocortical neural transplants by H-2 incompatible mice. J Immunol (1987) 0.88
Molecular evolution of tau protein: implications for Alzheimer's disease. J Neurochem (1996) 0.87
Developmental alterations in molecular weights of proteins in the human central nervous system that react with antibodies against myelin-associated glycoprotein. J Cell Biol (1984) 0.86
Focal brain injury and upregulation of a developmentally regulated extracellular matrix protein. J Neurosurg (1995) 0.86
Chromosomal localization of the human hexabrachion (tenascin) gene and evidence for recent reduplication within the gene. Genomics (1990) 0.86
Binding of hexabrachions to heparin and DNA. J Biol Chem (1989) 0.86
Mechanism of oxyhemoglobin-induced release of endothelin-1 from cultured vascular endothelial cells and smooth-muscle cells. J Neurosurg (1993) 0.86
Nitric oxide synthase and guanylate cyclase levels in canine basilar artery after subarachnoid hemorrhage. J Neurosurg (1995) 0.85
Long PCR detection of the C4A null allele in B8-C4AQ0-C4B1-DR3. J Immunol Methods (2000) 0.83
Screen for CACNA1A and ATP1A2 mutations in sporadic hemiplegic migraine patients. Cephalalgia (2008) 0.83
CDKN2A mutations and melanoma risk in the Icelandic population. J Med Genet (2008) 0.82
Expression of tenascin in thymus and thymic nonlymphoid cells. J Immunol (1994) 0.82
The oligodendrocyte-myelin glycoprotein of mouse: primary structure and gene structure. Genomics (1993) 0.82
Endometriosis is not associated with or linked to the GALT gene. Fertil Steril (2001) 0.82
Neuronal-specific enolase in human corneal endothelium and posterior keratocytes. Exp Eye Res (1985) 0.82
Dinucleotide repeat polymorphism for the hexabrachion gene (HXB) on chromosome 9q32-34. Hum Mol Genet (1992) 0.81
Structure and chromosomal localization of the gene for the oligodendrocyte-myelin glycoprotein. J Cell Biol (1990) 0.80
Myelin-associated glycoprotein in human retina. Nature (1984) 0.80
Myelin-associated glycoprotein in the developing human retina. Exp Eye Res (1986) 0.79
Beta-trace gene expression is regulated by a core promoter and a distal thyroid hormone response element. J Biol Chem (1997) 0.79
Distribution of S-100 protein and glial fibrillary acidic protein in normal and gliotic human retina. Exp Eye Res (1984) 0.78
Developmental changes in the molecular weights of polypeptides in the human CNS that carry the HNK-1 epitope and bind Phaseolus vulgaris lectins. J Neurochem (1988) 0.78
Pattern of reactivity of IgM from the sera of eight patients with IgM monoclonal gammopathy and neuropathy with components of neural tissues: evidence for interaction with more than one epitope. Acta Neuropathol (1985) 0.78
Peripheral neuropathy, high serum IgM, and paraproteinemia in mother and son. Neurology (1985) 0.78
Paraneoplastic myelopathy: antibodies against protein in normal spinal cord and underlying neoplasm. Lancet (1985) 0.78
Genome-wide TDT analysis in a localized population with a high prevalence of multiple sclerosis indicates the importance of a region on chromosome 14q. Genes Immun (2003) 0.78
Autosomal dominant cerebrovascular amyloidosis: properties of peripheral blood lymphocytes. Ann Neurol (1980) 0.77
Species variations in distribution of S100 in retina. Demonstration with a monoclonal antibody and a polyclonal antiserum. Invest Ophthalmol Vis Sci (1985) 0.77
Monoclonal antibodies and lectins as probes for investigation of the cell biology of human trabecular meshwork: a preliminary report. Ophthalmic Res (1989) 0.77
Exposure of binding sites for antibodies and concanavalin A on collagen by solubilization in hot urea. An immunoblot analysis. J Immunol Methods (1986) 0.76
An in vivo and in vitro analysis of systemic immune function in mice with histologic evidence of neural transplant rejection. J Neurosci Res (1987) 0.76
Is multiple sclerosis an autoimmune disease? Clin Neurosci (1994) 0.75
Suramin: is adaptive control necessary? J Clin Oncol (1992) 0.75
Genealogy certainly matters for multifactorial genetic disease. BMJ (1999) 0.75
A biochemically distinct sub-population of neurons in the human substantia gelatinosa. Study with G-6-PD histochemistry. J Neurol Sci (1982) 0.75
Molecular mimicry and microorganisms: a role in the pathogenesis of myasthenia gravis? Curr Top Microbiol Immunol (1989) 0.75
Cloning of cDNA for two large polypeptides found in myelinating oligodendrocytes. Ann N Y Acad Sci (1988) 0.75
Tuberous sclerosis. Mayo Clin Proc (1991) 0.75
Experimental allergic neuritis in the SJL/J mouse: dysfunction of peripheral nerve without clinical signs. J Neuroimmunol (1991) 0.75
Muscle acid protease activity in amyotrophic lateral sclerosis: correlation with clinical and pathologic features. Neurology (1982) 0.75
SAG: a Schwann cell membrane glycoprotein. J Neurosci (1992) 0.75
A peanut agglutinin binding glycoprotein in CNS myelin and oligodendrocytes. Ann N Y Acad Sci (1988) 0.75
Monoclonal antibodies to human trabecular endothelium. A preliminary report on production and characterization. Exp Eye Res (1986) 0.75
A 70-kd polypeptide secreted by human peripheral blood mononuclear cells that suppresses proliferation of a human glioblastoma cell line. Ann N Y Acad Sci (1988) 0.75
Gene warrior. Interview by Ehsan Masood. New Sci (2000) 0.75
Generation of monoclonal antibodies recognizing neuronal elements in formalin-fixed paraffin-embedded human tissue. J Neuropathol Exp Neurol (1985) 0.75
A phenotypic analysis of T lymphocytes isolated from the brains of mice with allogeneic neural transplants. Prog Brain Res (1988) 0.75
The hexabrachion gene as a candidate for a tuberous sclerosis gene. Ann N Y Acad Sci (1991) 0.75
Prevention of neural allograft rejection in the mouse following in vivo depletion of L3T4+ but not LYT-2+ T-lymphocytes. Prog Brain Res (1990) 0.75
An epitope shared by central nervous system myelin and peripheral blood macrophages. J Neuroimmunol (1986) 0.75